Related Experiment Videos
Formulary decision-making considerations: COX-2 inhibitors
Fadia T Shaya1, Winston Wong, James Y Shin
1Center on Drugs & Public Policy, University of Maryland School of Pharmacy, Baltimore 21201, USA. fshaya@rx.umaryland.edu
Managed Care Interface
|December 3, 2004
Summary
Pharmacy & Therapeutics Committees evaluate drug safety and efficacy over cost when determining formulary status. The cyclooxygenase-2 inhibitors case offers insights into these complex medication decisions.
Area of Science:
- Pharmacoeconomics
- Clinical Pharmacy
- Drug Therapeutics
Background:
- Pharmacy & Therapeutics (P&T) Committees face complex decisions regarding drug formulary placement.
- Key considerations include clinical efficacy, patient safety, economic impact, and available alternatives.
Purpose of the Study:
- To analyze the decision-making process for drug formulary status.
- To examine the influence of drug safety and efficacy versus economic factors.
Main Methods:
- Review of factors influencing P&T Committee decisions.
- Case study analysis of cyclooxygenase-2 (COX-2) inhibitors for arthritis treatment.
Main Results:
- Safety and effectiveness often outweigh economic considerations in formulary decisions.
- The COX-2 inhibitor case highlights the interplay of clinical and financial factors.
Conclusions:
- Formulary decisions prioritize clinical attributes over cost.
- Understanding these dynamics is crucial for effective medication management and P&T Committee operations.